Family & Community Medicine
Family & Community Medicine
Stanford Family Medicine strives to engage in and promote primary care and prevention research focused on local, regional, national and international health issues. Faculty in the O'Connor Family Medicine Residency, Primary Care Associate Program, Stanford Geriatric Education Center, Stanford Family Medicine Clinic, Area Health Education Center and others conduct research in chronic care, personalized medicine, epidemiology, ethnogeriatrics, education, integrative medicine and community health.
Family & Community Medicine News
-
Transplant surgeon Oscar Salvatierra dies
Oscar Salvatierra founded Stanford’s pediatric kidney transplant program, helped write the national legislation that regulates organ transplants, and conducted research in kidney transplantation.
-
Mystery novel and dream spur key insight
On Dec. 14, 2014, after many months of not getting expected results, biochemist Jim Spudich got into bed, read a chunk of a novel, fell asleep and had a dream that would change the focus of his entire field in thinking about what causes a common and often lethal heart defect.
-
Edward Rubenstein dies at 94
Edward Rubenstein was an internist, an educator and an investigator of varied research topics, including synchrotron medical imaging.
Upcoming Courses
Conferences and Workshops
-
07/18/2019
27th Annual Pediatric Update and Pre-Conference: What’s New in Allergy and Pulmonology 2019
The Frances C. Arrillaga Alumni Center, Stanford, CA
-
08/24/2019
8th Annual Navigating Spine Care
Fisher Conference Center at the Arrillaga Alumni Center, Stanford, CA
-
09/14/2019
Emerging Research, Diagnosis and Treatment of Lyme Disease and Tick-Borne Illness
Li Ka Shing Center for Learning & Knowledge, Stanford, CA
New courses are added regularly— please check back often
Online Courses
- Managing Atrial Fibrillation
- Unconscious Bias
- Health Across the Gender Spectrum
- SafetyQuest: Level four - Mastering QI
- SafetyQuest: Level Three - Implementing QI
- SafetyQuest: Level One - QI Basics
- SafetyQuest: Level Two - Moving Beyond QI Basics
- Locating and Using Medical Information in the Digital Age
- Statistics for Medical Professionals
- Writing in Science
- Thinking Critically: Interpreting Screening Trials
- Thinking Critically: Interpreting Randomized Clinical Trials
- Prescription Drug Misuse and Addiction: Compassionate Care for a Complex Problem
- To Prescribe or Not To Prescribe? Antibiotics and Outpatient Infections
- Optimizing Antimicrobial Therapy with Timeouts
- Dementia and Diversity in Primary Care: A Primer - Guidelines, Ethnic Differences, and Assessment
- Dementia and Diversity in Primary Care: South Asian Populations
- Dementia and Diversity in Primary Care: Latino Populations
- Dementia and Diversity in Primary Care: African American Populations
- Introduction to Food and Health
- Hypertension in Primary Care - Improving Control and Reducing Risk
- HealthPro Advantage: Anti-Doping Education For The Health Professional
- Identifying Early Signs of Psychosis in Adolescents and Young Adults
- Presentation and Management of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
- NETs 101
- An Evidence-Based Approach to the Diagnosis and Management of Migraines in Adults in the Primary Care and General Neurology Setting
- E-Cigarettes: Harmful or Harm-Reducing
- Type 2 Diabetes Management
- CSI:ME Case Studies in Medical Errors
- SonoDoc: Case-Based Learning in Bedside Ultrasound
- Practical Tips to Improve Asian American Participation in Cancer Clinical Trials
- Musculoskeletal Medicine Primer for the non-Orthopedist
- Congenital Hypothyroidism: What Every Primary Care Provider Needs to Know
- Screening and Assessing Depression in Primary Care Settings: Clinical and Ethical Considerations
Mailing List
New activities are added regularly. Join our mailing list to receive email notifications about activities of interest to you.
Related Clinical Trials
Showing 1 - 20 of 101 trials
-
Pathway to Prevention Study
Stanford is currently accepting patients for this trial. -
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
Stanford is currently accepting patients for this trial.